AI MARKET SCANNING

Atara Biotherapeutics, Inc.

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP -0.37%
MAX GAP RECORD +13.31%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ATRA
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 12, 2026 Earnings Release 2026-08-12 (AFTER CLOSE)
-9.59%
Mar 16, 2026 Earnings Release 2026-03-16 (AFTER CLOSE)
-2.21%
Nov 12, 2025 Earnings Release 2025-11-12 (BEFORE OPEN)
-1.59%
Aug 11, 2025 Earnings Release 2025-08-11 (AFTER CLOSE)
+6.69%
May 15, 2025 Earnings Release 2025-05-15 (BEFORE OPEN)
+13.31%
Mar 07, 2025 Earnings Release 2025-03-07 (AFTER CLOSE)
+0.29%
Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE)
+2.83%
Aug 12, 2024 Earnings Release 2024-08-12 (AFTER CLOSE)
+0.39%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.5%
Bullish Gaps (4)
Bearish Gaps (6)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ATRA

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗